A renowned technology analyst and investor, Lou Basenese left Wall Street in 2005 to become a financial publishing pioneer. Since then, Basenese has been credited with over 25,000 technology-related essays, covering every meaningful trend and boom over the last 16 years — from immunotherapy to Bitcoin… smartphones to artificial intelligence… 3-D printing to biometrics… and beyond.
Basenese also regularly lends his wisdom and expertise to major broadcasting and media outlets like Fox Business and CNBC, among others. A tireless advocate of Main Street investors the world over, Basenese has founded (or partnered with) over 10 multimillion-dollar businesses, and he’s even helped deploy capital into startups and other embryonic technologies.
With his deep market insights – the result of helping to direct over $1.5 billion in institutional capital for Morgan Stanley – these days, Basenese serves as Chief Investment Strategist for Trend Trader Daily; a free, no-nonsense publication that bridges the information gap between Wall Street and everyday investors. Underpinned by Basenese’s 16-year track record, Trend Trader Daily identifies the market’s biggest, most impactful, paradigm-smashing trends – ones with the power to radically impact lives and fortunes. Basenese is also the Founder of Disruptive Tech Research, a leading technology research and advisory firm that focuses on patent-filing activity to identify the most promising emerging technology trends.
When Friday rolls around in the Trend Trader Daily Nation, you know the drill: We roll out the charts! After all, a picture is said to be worth a thousand words — and there’s no easier way to say a lot without saying anything at all than sharing several compelling pictures… read more »Friday, June 11, 2021
Don’t fall for the latest propaganda in the financial press! The latest Bloomberg article on so-called “meme stocks” completely misses the mark when it comes articulating what’s going on right now. I break it all down in the video below, including the one takeaway we can learn from how traders are… read more »Thursday, June 10, 2021
Sorry, LL Cool J. But I’m calling this a comeback! On the heels of yesterday’s historic decision by the FDA to approve the first drug in 20 years to treat Alzheimer’s disease, forget about Biogen’s (BIIB) stock rally… all biotech stocks rallied big! Take a look: (click image to enlarge)… read more »Tuesday, June 8, 2021
If you're new to the Trend Trader Daily Nation, here's the rundown... Each Friday, I embrace the adage that "a picture is worth a thousand words," and hand-select compelling charts to put important investment and economic news into perspective. All it takes is a quick glance — and you'll be up… read more »Friday, June 4, 2021
Several weeks ago, I alerted you to the resurgence of interest in gene therapy stocks by providing you with three compelling and undeniable data points. Of course, not everyone is persuaded by data. Some investors need to “see” the trend before they’ll believe it and buy it. Well, ask and… read more »Thursday, June 3, 2021